| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |